US 11932635
CRBN ligands and uses thereof
granted A61PA61P35/00
Quick answer
US patent 11932635 (CRBN ligands and uses thereof) held by Kymera Therapeutics, Inc. expires Mon Mar 14 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Kymera Therapeutics, Inc.
- Grant date
- Tue Mar 19 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 14 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 21
- CPC classes
- A61P, A61P35/00